menu
    • menu

    Company profile for PellePharm

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PellePharm leads the way in applying precision medicine to dermatology. PellePharm is a biotechnology company committed to targeting rare dermatologic diseases at the source. Founded by world leaders in hedgehog signaling, PellePharm is working to improve the quality of life for those suffering from Gorlin Syndrome and BCCs by providing an easy-to-use topical solution that eliminates the need for regular, painful surgeries.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PellePharmUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    101 Mission Street Suite 2050 San Francisco, CA 94105
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pellepharm.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/pellepharm
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BridgeBio company sells off rare disease candidate to Galderma partner
    BridgeBio company sells off rare disease candidate to Galderma partner

    28 Jan 2023

    // Paul Schloesser ENDPTS

    https://endpts.com/bridgebio-company-sells-off-rare-disease-candidate-to-galderma-partner/

    Paul Schloesser ENDPTS
    28 Jan 2023
    Share Share
    PellePharm to Highlight Clinical Programs at the 29th Congress
    PellePharm to Highlight Clinical Programs at the 29th Congress

    29 Oct 2020

    // PRESSRELEASE

    https://www.pharmacompass.com/pdf/news/pellepharm-to-highlight-clinical-programs-at-the-29th-congress-1605859136.pdf

    PRESSRELEASE
    29 Oct 2020
    Share Share
    PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel
    PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel

    08 Jan 2020

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20200108005191/en

    BUSINESS WIRE
    08 Jan 2020
    Share Share
    PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel
    PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel

    08 Jan 2020

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20200108005191/en

    BUSINESS WIRE
    08 Jan 2020
    Share Share
    PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel
    PellePharm Initiates Phase 2 Clinical Trial of Patidegib Topical Gel

    07 Jan 2020

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20200108005191/en

    BUSINESS WIRE
    07 Jan 2020
    Share Share
    PellePharm Completes of Pivotal Ph3 Clinical Trial of Patidegib Topical Gel
    PellePharm Completes of Pivotal Ph3 Clinical Trial of Patidegib Topical Gel

    02 Dec 2019

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20191202005270/en

    BUSINESS WIRE
    02 Dec 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search